Skip to Content
You are currently on the new version of our website. Access the old version .

2,271 Results Found

  • Review
  • Open Access
7 Citations
3,288 Views
16 Pages

Circulating DNA has already proven itself as a valuable tool in translational medicine. However, one of the overlooked areas of circulating DNA research is its association with different proteins, despite considerable evidence that this association m...

(This article belongs to the Special Issue Proteomics and Its Applications in Cancers)
  • Review
  • Open Access
45 Citations
7,381 Views
23 Pages

Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers

  • Sridevi Addanki,
  • Salyna Meas,
  • Vanessa Nicole Sarli,
  • Balraj Singh and
  • Anthony Lucci

Liquid biopsies allow for the detection of cancer biomarkers such as circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA). Elevated levels of these biomarkers during cancer treatment could potentially serve as indicators of cancer progres...

(This article belongs to the Special Issue Liquid Biopsies in Oncology)
  • Review
  • Open Access
9 Citations
7,315 Views
9 Pages

Clinical Applications of Circulating Tumour DNA in Pancreatic Adenocarcinoma

  • Matthew Loft,
  • Belinda Lee,
  • Jeanne Tie and
  • Peter Gibbs

Pancreatic adenocarcinoma remains one of the most aggressive cancers with an ongoing dismal survival rate despite some recent advances in treatment options. This is largely due to the typically late presentation and limited effective therapeutic opti...

  • Review
  • Open Access
42 Citations
7,072 Views
13 Pages

Circulating Microbial Cell-Free DNA in Health and Disease

  • Bernadeta Pietrzak,
  • Iwona Kawacka,
  • Agnieszka Olejnik-Schmidt and
  • Marcin Schmidt

3 February 2023

Human blood contains low biomass of circulating microbial cell-free DNA (cfmDNA) that predominantly originates from bacteria. Numerous studies have detected circulating cfmDNA in patients with infectious and non-infectious diseases, and in healthy in...

(This article belongs to the Special Issue Latest Review Papers in Molecular and Cellular Biology 2023)
  • Review
  • Open Access
19 Citations
5,207 Views
21 Pages

Role of Circulating Tumor DNA in Hematological Malignancy

  • Miho Ogawa,
  • Kazuaki Yokoyama,
  • Seiya Imoto and
  • Arinobu Tojo

25 April 2021

With the recent advances in noninvasive approaches for cancer diagnosis and surveillance, the term “liquid biopsy” has become more familiar to clinicians, including hematologists. Liquid biopsy provides a variety of clinically useful genetic data. In...

  • Perspective
  • Open Access
40 Citations
7,052 Views
16 Pages

Electrochemical Biosensors for Circulating Tumor DNA Detection

  • Ke Wang,
  • Zhijia Peng,
  • Xiaogang Lin,
  • Weiqi Nian and ,
  • Xiaodong Zheng and
  • Jayne Wu
  • + 1 author+ 0 author

17 August 2022

Early diagnosis and treatment have always been highly desired in the fight against cancer, and detection of circulating tumor DNA (ctDNA) has recently been touted as highly promising for early cancer-screening. Consequently, the detection of ctDNA in...

(This article belongs to the Section Biosensors and Healthcare)
  • Review
  • Open Access
99 Citations
9,844 Views
23 Pages

11 December 2020

Breast cancer is the most common cancer among women worldwide. Although the five-, ten- and fifteen-year survival rates are good for breast cancer patients diagnosed with early-stage disease, some cancers recur many years after completion of primary...

(This article belongs to the Special Issue Liquid Biopsies in Cancer Diagnosis, Monitoring and Prognosis)
  • Review
  • Open Access
28 Citations
6,355 Views
23 Pages

Dual Biomarker Strategies for Liquid Biopsy: Integrating Circulating Tumor Cells and Circulating Tumor DNA for Enhanced Tumor Monitoring

  • Ga Young Moon,
  • Basak Dalkiran,
  • Hyun Sung Park,
  • Dongjun Shin and ,
  • Chaeyeon Son,
  • Jung Hyun Choi,
  • Seha Bang,
  • Hosu Lee,
  • Il Doh and
  • Jiyoon Bu
  • + 7 authors+ 2 authors

28 January 2025

The liquid biopsy has gained significant attention in cancer diagnostics, with circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) being recognized as key biomarkers for tumor detection and monitoring. However, each biomarker possesses i...

(This article belongs to the Special Issue Immunoassays and Biosensing (2nd Edition))
  • Review
  • Open Access
5 Citations
1,250 Views
10 Pages

13 October 2020

Tumour molecular features are increasingly linked to treatment response and patient prognosis in advanced prostate cancer. Plasma cell-free circulating tumour DNA (ctDNA) isolated from a minimally invasive blood draw offers a convenient source of tum...

  • Article
  • Open Access
17 Citations
3,548 Views
15 Pages

Quantification of Circulating Cell-Free DNA in Idiopathic Parkinson’s Disease Patients

  • Małgorzata Wojtkowska,
  • Natalia Karczewska,
  • Klaudia Pacewicz,
  • Andrzej Pacak and ,
  • Piotr Kopeć,
  • Jolanta Florczak-Wyspiańska,
  • Karolina Popławska-Domaszewicz,
  • Tomasz Małkiewicz and
  • Bartosz Sokół
  • + 4 authors+ 0 author

29 February 2024

Parkinson’s disease (PD) is one of the most common neurodegenerative disorders globally and leads to an excessive loss of dopaminergic neurons in the substantia nigra of the brain. Circulating cell-free DNA (ccf-DNA) are double-stranded DNA fra...

(This article belongs to the Special Issue Role of Mitochondria in Diseases)
  • Review
  • Open Access
22 Citations
4,610 Views
14 Pages

Circulating Tumour DNA in Muscle-Invasive Bladder Cancer

  • Melissa P. Tan,
  • Gerhardt Attard and
  • Robert A. Huddart

Circulating tumour DNA (ctDNA) is an attractive tool in cancer research, offering many advantages over tissue samples obtained using traditional biopsy methods. There has been increasing interest in its application to muscle-invasive bladder cancer (...

(This article belongs to the Special Issue Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer – Illumination of a Vision)
  • Review
  • Open Access
33 Citations
8,208 Views
22 Pages

Circulating Tumor DNA in the Management of Early-Stage Breast Cancer

  • Katerina Vlataki,
  • Sevastiani Antonouli,
  • Christina Kalyvioti,
  • Evangeli Lampri and ,
  • Sevasti Kamina,
  • Davide Mauri,
  • Haralampos V. Harissis and
  • Angeliki Magklara
  • + 3 authors+ 0 author

7 June 2023

Liquid biopsies refer to the isolation and analysis of tumor-derived biological material from body fluids, most commonly blood, in order to provide clinically valuable information for the management of cancer patients. Their non-invasive nature allow...

(This article belongs to the Special Issue Current Status and Future Challenges of Liquid Biopsy)
  • Review
  • Open Access
17 Citations
5,283 Views
28 Pages

The Position of Circulating Tumor DNA in the Clinical Management of Colorectal Cancer

  • Ana Regina de Abreu,
  • Ken Op de Beeck,
  • Pierre Laurent-Puig,
  • Valerie Taly and
  • Leonor Benhaim

17 February 2023

Colorectal cancer (CRC) is the third most common cancer type worldwide, with over 1.9 million new cases and 935,000 related deaths in 2020. Within the next decade, the incidence of CRC is estimated to increase by 60% and the mortality by 80%. One of...

(This article belongs to the Section Cancer Biomarkers)
  • Article
  • Open Access
28 Citations
6,530 Views
14 Pages

Blood Plasma Exosomes Contain Circulating DNA in Their Crown

  • Oleg Tutanov,
  • Tatiana Shtam,
  • Alina Grigor’eva,
  • Alexey Tupikin and ,
  • Yuri Tsentalovich and
  • Svetlana Tamkovich
  • + 1 author+ 0 author

It is known that circulating DNA (cirDNA) is protected from nuclease activity by proteins that form macromolecular complexes with DNA. In addition, it was previously shown that cirDNA can bind to the outer surface of exosomes. NTA analysis and real-t...

(This article belongs to the Special Issue Cell-Free Nucleic Acids—New Insights into Physico-Chemical Properties, Analytical Considerations, and Clinical Applications)
  • Article
  • Open Access
7 Citations
3,257 Views
11 Pages

5 May 2022

The detection of circulating tumor DNA is a major challenge in liquid biopsies for cancer. Conventionally, quantitative polymerase chain reactions or next-generation sequencing are used to detect circulating tumor DNA; however, these techniques requi...

(This article belongs to the Section Polymeric Materials)
  • Review
  • Open Access
13 Citations
5,191 Views
15 Pages

The study of molecular drivers of cancer is an area of rapid growth and has led to the development of targeted treatments, significantly improving patient outcomes in many cancer types. The identification of actionable mutations informing targeted tr...

(This article belongs to the Special Issue Advanced Molecular Solutions for Cancer Therapy)
  • Review
  • Open Access
19 Citations
5,250 Views
11 Pages

13 June 2020

Liquid biopsy is a minimally invasive method for detecting soluble factors, including circulating tumor DNA (ctDNA), in body fluids. ctDNA carrying tumor-specific genetic or epigenetic alterations is released into circulation from tumor cells. ctDNA...

(This article belongs to the Collection Cancer Biomarkers)
  • Review
  • Open Access
37 Citations
8,007 Views
26 Pages

Decoding the Dynamics of Circulating Tumor DNA in Liquid Biopsies

  • Khadija Turabi,
  • Kelsey Klute and
  • Prakash Radhakrishnan

1 July 2024

Circulating tumor DNA (ctDNA), a fragment of tumor DNA found in the bloodstream, has emerged as a revolutionary tool in cancer management. This review delves into the biology of ctDNA, examining release mechanisms, including necrosis, apoptosis, and...

(This article belongs to the Collection Cancer Biomarkers in Body Fluids)
  • Review
  • Open Access
13 Citations
4,527 Views
14 Pages

Towards Circulating-Tumor DNA-Based Precision Medicine

  • Ai Hironaka-Mitsuhashi,
  • Anna Sanchez Calle,
  • Takahiro Ochiya,
  • Shin Takayama and
  • Akihiko Suto

2 September 2019

In the era of precision medicine, targeted therapies have been implemented for various diseases. Genomic information guides decision-making in cancer treatment. The improvements in next-generation sequencing and polymerase chain reaction have made it...

(This article belongs to the Section Clinical Laboratory Medicine)
  • Article
  • Open Access
37 Citations
6,475 Views
19 Pages

Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma

  • Preawwalee Wintachai,
  • Jing Quan Lim,
  • Anchalee Techasen,
  • Worachart Lert-itthiporn and ,
  • Sarinya Kongpetch,
  • Watcharin Loilome,
  • Jarin Chindaprasirt,
  • Attapol Titapun,
  • Nisana Namwat and
  • Apinya Jusakul
  • + 6 authors+ 1 author

The analysis of cfDNA has been applied as a liquid biopsy in several malignancies. However, its value in the diagnosis and prognosis of cholangiocarcinoma (CCA) have not been well defined. We aimed to investigate the diagnostic and prognostic values...

(This article belongs to the Collection Biomarkers in Medicine)
  • Review
  • Open Access
1 Citations
5,340 Views
19 Pages

Is Circulating DNA and Tumor Cells in Myeloma the Way Forward?

  • Emilie Arnault Carneiro,
  • Filipa Barahona,
  • Carolina Pestana and
  • Cristina João

13 January 2022

Multiple myeloma (MM) is the second deadliest hematological cancer. Despite the enormous innovation on MM treatment in the last decades, still 48% of patients die within 5 years after diagnosis. MM diagnosis and therapeutic strategy mainly rely on di...

(This article belongs to the Special Issue Current and Upcoming Diagnostics and Prognostics in Multiple Myeloma)
  • Review
  • Open Access
38 Citations
6,221 Views
20 Pages

The Promise of Circulating Tumor DNA in Head and Neck Cancer

  • Sukhkaran S. Aulakh,
  • Dustin A. Silverman,
  • Kurtis Young,
  • Steven K. Dennis and
  • Andrew C. Birkeland

16 June 2022

As the seventh most common cancer globally, head and neck cancers (HNC) exert considerable disease burden, with an estimated 277,597 deaths worldwide in 2020 alone. Traditional risk factors for HNC include tobacco, alcohol, and betel nut; more recent...

(This article belongs to the Special Issue Cell-Free DNA as Prognostic and Predictive Biomarker in Solid Cancers)
  • Review
  • Open Access
45 Citations
9,593 Views
19 Pages

Genetics of Hepatocellular Carcinoma: From Tumor to Circulating DNA

  • Claudia Campani,
  • Jessica Zucman-Rossi and
  • Jean-Charles Nault

28 January 2023

Hepatocellular carcinoma (HCC) accounts for 90% of primary hepatic malignancies and is one of the major causes of cancer-related death. Over the last 15 years, the molecular landscape of HCC has been deciphered, with the identification of the main dr...

(This article belongs to the Section Molecular Cancer Biology)
  • Review
  • Open Access
20 Citations
5,860 Views
15 Pages

Impact of Circulating Cell-Free DNA (cfDNA) as a Biomarker of the Development and Evolution of Periodontitis

  • Gaia Viglianisi,
  • Simona Santonocito,
  • Alessandro Polizzi,
  • Giuseppe Troiano and ,
  • Mariacristina Amato,
  • Khrystyna Zhurakivska,
  • Paolo Pesce and
  • Gaetano Isola
  • + 3 authors+ 0 author

In the last few decades, circulating cell-free DNA (cfDNA) has been shown to have an important role in cell apoptosis or necrosis, including in the development and evolution of several tumors and inflammatory diseases in humans. In this regard, perio...

(This article belongs to the Special Issue Pathogenesis and Therapy of Oral Carcinogenesis)
  • Review
  • Open Access
6 Citations
2,705 Views
19 Pages

18 November 2025

The role of circulating tumor DNA (ctDNA) in gastroesophageal adenocarcinoma (GEA) has expanded in recent years. In resectable disease, postoperative ctDNA is able to detect patients at highest risk of recurrence months before scans. Tumor-informed a...

(This article belongs to the Special Issue Cell-Free DNA as Prognostic and Predictive Biomarker in Solid Cancers (2nd Edition))
  • Review
  • Open Access
14 Citations
3,647 Views
13 Pages

15 May 2024

Biomarkers for evaluating tumor response to therapy and estimating the risk of disease relapse represent tremendous areas of clinical need. To evaluate treatment efficacy, tumor response is routinely assessed using different imaging modalities like p...

(This article belongs to the Special Issue Imaging and Liquid Biopsy Biomarkers for Cancer Diagnosis and Treatment)
  • Article
  • Open Access
43 Citations
6,067 Views
14 Pages

The Diagnostic Value of Circulating Cell-Free HPV DNA in Plasma from Cervical Cancer Patients

  • Sara Bønløkke,
  • Magnus Stougaard,
  • Boe Sandahl Sorensen,
  • Berit Bargum Booth and ,
  • Estrid Høgdall,
  • Gitte-Bettina Nyvang,
  • Jacob Christian Lindegaard,
  • Jan Blaakær,
  • Jesper Bertelsen and
  • Torben Steiniche
  • + 8 authors+ 3 authors

11 July 2022

Circulating cell-free HPV DNA (ccfHPV DNA) may serve as a marker for cervical cancer. In this study, we used digital droplet PCR (ddPCR) to detect and quantify ccfHPV DNA in plasma from patients with HPV16- or HPV18-associated cervical cancer. Blood...

(This article belongs to the Special Issue Molecular and Immunological Mechanisms of HPV-Induced Carcinogenesis)
  • Review
  • Open Access
34 Citations
5,252 Views
16 Pages

Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic Cancer

  • Jedrzej J. Jaworski,
  • Robert D. Morgan and
  • Shivan Sivakumar

9 December 2020

Pancreatic cancer is a lethal disease, with mortality rates negatively associated with the stage at which the disease is detected. Early detection is therefore critical to improving survival outcomes. A recent focus of research for early detection is...

(This article belongs to the Special Issue Molecular Biomarkers and Precision Medicine for Pancreatic, Liver and Biliary Tract Cancers)
  • Article
  • Open Access
26 Citations
4,510 Views
14 Pages

DNA-Repair Gene Mutations Are Highly Prevalent in Circulating Tumour DNA from Multiple Myeloma Patients

  • Sridurga Mithraprabhu,
  • Jay Hocking,
  • Malarmathy Ramachandran,
  • Kawa Choi and ,
  • Daniela Klarica,
  • Tiffany Khong,
  • John Reynolds and
  • Andrew Spencer
  • + 3 authors+ 0 author

29 June 2019

Mutational characterisation utilising plasma (PL)-derived circulating tumour DNA (ctDNA) in multiple myeloma (MM) has been recently described. Mutational analyses of paired bone marrow (BM) MM cell DNA and ctDNA from 76 patients (n = 24, new diagnosi...

(This article belongs to the Special Issue Liquid Biopsy for Cancer)
  • Article
  • Open Access
55 Citations
10,926 Views
11 Pages

Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer

  • Susan M. Mitchell,
  • Thu Ho,
  • Glenn S. Brown,
  • Rohan T. Baker and ,
  • Melissa L. Thomas,
  • Aidan McEvoy,
  • Zheng-Zhou Xu,
  • Jason P. Ross,
  • Trevor J. Lockett and
  • Peter L. Molloy
  • + 8 authors+ 3 authors

15 December 2016

Solid tumors shed DNA into circulation, and there is growing evidence that the detection of circulating tumor DNA (ctDNA) has broad clinical utility, including monitoring of disease, prognosis, response to chemotherapy and tracking tumor heterogeneit...

(This article belongs to the Special Issue Cancer Genetics)
  • Review
  • Open Access
215 Citations
18,395 Views
34 Pages

The Clinical Utilization of Circulating Cell Free DNA (CCFDNA) in Blood of Cancer Patients

  • Yahya I. Elshimali,
  • Husseina Khaddour,
  • Marianna Sarkissyan,
  • Yanyuan Wu and
  • Jaydutt V. Vadgama

13 September 2013

Qualitative and quantitative testing of circulating cell free DNA (CCFDNA) can be applied for the management of malignant and benign neoplasms. Detecting circulating DNA in cancer patients may help develop a DNA profile for early stage diagnosis in m...

(This article belongs to the Special Issue Advances in Cancer Diagnosis)
  • Review
  • Open Access
81 Citations
15,806 Views
25 Pages

Circulating tumor DNA (ctDNA) is a component of cell-free DNA (cfDNA) that is shed by malignant tumors into the bloodstream and other bodily fluids. ctDNA can comprise up to 10% of a patient’s cfDNA depending on their tumor type and burden. The...

(This article belongs to the Special Issue Liquid Biopsies in Oncology)
  • Systematic Review
  • Open Access
33 Citations
4,940 Views
16 Pages

Circulating Tumour DNA as Biomarker for Colorectal Liver Metastases: A Systematic Review and Meta-Analysis

  • Lissa Wullaert,
  • Jan M. van Rees,
  • John W. M. Martens,
  • Henk M. W. Verheul and ,
  • Dirk J. Grünhagen,
  • Saskia M. Wilting and
  • Cornelis Verhoef
  • + 2 authors+ 0 author

25 October 2023

Circulating tumour DNA (ctDNA) is a potential biomarker that could contribute to more judicious patient selection for personalised treatment. This review and meta-analysis gives an overview of the current knowledge in the literature investigating the...

(This article belongs to the Special Issue Molecular Mechanisms of Liver Metastases)
  • Review
  • Open Access
115 Views
21 Pages

Revealing the Invisible: Circulating and Urinary Tumor DNA in Bladder Cancer

  • Sophia L. Qin,
  • Benista Owusu-Amo and
  • David T. Miyamoto

6 November 2026

Muscle-invasive bladder cancer (MIBC) carries a high risk of recurrence and metastatic progression despite aggressive treatment with radical cystectomy or trimodality therapy. Current surveillance methods, including imaging and cystoscopy, have limit...

(This article belongs to the Special Issue Advances in Treatment of Bladder Cancer)
  • Review
  • Open Access
53 Citations
10,925 Views
23 Pages

Characterization of DNA Methylation in Circulating Tumor Cells

  • Constantin F. Pixberg,
  • Wolfgang A. Schulz,
  • Nikolas H. Stoecklein and
  • Rui P. L. Neves

21 October 2015

Epigenetics contributes to molecular mechanisms leading to tumor cell transformation and systemic progression of cancer. However, the dynamics of epigenetic remodeling during metastasis remains unexplored. In this context, circulating tumor cells (CT...

(This article belongs to the Special Issue Epigenetic Biomarkers)
  • Review
  • Open Access
2,219 Views
8 Pages

19 July 2023

Liquid biopsy has demonstrated success as a diagnostic, prognostic, and therapy response monitoring tool in various cancers and could represent a rapid and minimally invasive alternative or complementary test for testicular germ cell tumors (GCTs). T...

  • Review
  • Open Access
19 Citations
4,166 Views
11 Pages

The Emerging Role of Circulating Tumor DNA in the Management of Breast Cancer

  • Mira Shoukry,
  • Sacha Broccard,
  • Jamie Kaplan and
  • Emmanuel Gabriel

29 July 2021

With the incidence of breast cancer steadily rising, it is important to explore novel technologies that can allow for earlier detection of disease as well more a personalized and effective treatment approach. The concept of “liquid biopsies” and the...

(This article belongs to the Special Issue Circulating Tumor Cells: From the Laboratory to the Cancer Clinic)
  • Article
  • Open Access
28 Citations
5,909 Views
18 Pages

Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients

  • Patricia Mondelo-Macía,
  • Carmela Rodríguez-López,
  • Laura Valiña,
  • Santiago Aguín and ,
  • Luis León-Mateos,
  • Jorge García-González,
  • Alicia Abalo,
  • Oscar Rapado-González,
  • Mercedes Suárez-Cunqueiro and
  • Rafael López-López
  • + 13 authors+ 8 authors

24 February 2020

MET alterations may provide a potential biomarker to evaluate patients who will benefit from treatment with MET inhibitors. Therefore, the purpose of the present study is to investigate the utility of a liquid biopsy-based strategy to assess MET alte...

(This article belongs to the Special Issue Liquid Biopsy)
  • Article
  • Open Access
2 Citations
2,327 Views
17 Pages

Detection of Targetable Genetic Abnormalities in Neuroblastoma Circulating Tumour DNA

  • Marina Danilenko,
  • Sharanya Nath,
  • Jack Baines,
  • Freya Gordon and ,
  • Swathi Merugu,
  • Lisa M. Allinson,
  • Aaron Potts,
  • Bethany Collins,
  • Angharad Goodman and
  • Deborah A. Tweddle
  • + 8 authors+ 3 authors

27 September 2025

Neuroblastoma (NB) is an aggressive childhood cancer requiring intensive multimodal therapies in high-risk (HRNB) patients. Currently, invasive surgical biopsies are required to classify NB risk group and assign treatment based on the tumour genetic...

(This article belongs to the Special Issue 25th Anniversary of IJMS: Updates and Advances in Molecular Oncology)
  • Review
  • Open Access
32 Citations
5,250 Views
15 Pages

Circulating Tumor DNA in Gastric Adenocarcinoma: Future Clinical Applications and Perspectives

  • Giulia Grizzi,
  • Massimiliano Salati,
  • Maria Bonomi,
  • Margherita Ratti and ,
  • Lauren Holladay,
  • Maria Caterina De Grandis,
  • Daniele Spada,
  • Gian Luca Baiocchi and
  • Michele Ghidini
  • + 4 authors+ 0 author

Gastric cancer (GC) is still one of the most aggressive cancers with a few targetable alterations and a dismal prognosis. A liquid biopsy allows for identifying and analyzing the DNA released from tumor cells into the bloodstream. Compared to tissue-...

(This article belongs to the Special Issue Liquid Biopsy in Cancers)
  • Review
  • Open Access
15 Citations
5,300 Views
24 Pages

The Transformative Potential of Liquid Biopsies and Circulating Tumor DNA (ctDNA) in Modern Oncology

  • Keren Rouvinov,
  • Rashad Naamneh,
  • Alexander Yakobson,
  • Wenad Najjar and ,
  • Mahmoud Abu Amna,
  • Arina Soklakova,
  • Ez El Din Abu Zeid,
  • Ronen Brenner,
  • Mohnnad Asla and
  • Walid Shalata
  • + 8 authors+ 3 authors

Background: Liquid biopsy, particularly through the analysis of circulating tumor DNA (ctDNA), represents a significant advancement in oncology. Unlike traditional tissue biopsies, ctDNA offers a minimally invasive, real-time approach to cancer manag...

(This article belongs to the Special Issue Utilization of Liquid Biopsy in Cancer Diagnosis and Management 2025–2026)
  • Review
  • Open Access
52 Citations
11,800 Views
24 Pages

Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung Cancer

  • Misty Dawn Shields,
  • Kevin Chen,
  • Giselle Dutcher,
  • Ishika Patel and
  • Bruna Pellini

12 August 2022

Advancements in the clinical practice of non-small cell lung cancer (NSCLC) are shifting treatment paradigms towards increasingly personalized approaches. Liquid biopsies using various circulating analytes provide minimally invasive methods of sampli...

(This article belongs to the Special Issue Liquid Biopsies in Oncology)
  • Article
  • Open Access
17 Citations
4,878 Views
14 Pages

Analysis of the Whole-Exome Sequencing of Tumor and Circulating Tumor DNA in Metastatic Melanoma

  • Russell J. Diefenbach,
  • Jenny H. Lee,
  • Dario Strbenac,
  • Jean Y. H. Yang and ,
  • Alexander M. Menzies,
  • Matteo S. Carlino,
  • Georgina V. Long,
  • Andrew J. Spillane,
  • Jonathan R. Stretch and
  • Helen Rizos
  • + 10 authors+ 5 authors

29 November 2019

The use of circulating tumor DNA (ctDNA) to monitor cancer progression and response to therapy has significant potential but there is only limited data on whether this technique can detect the presence of low frequency subclones that may ultimately c...

  • Review
  • Open Access
1,516 Views
38 Pages

22 July 2026

Liquid biopsy has emerged as a transformative approach in modern oncology, offering minimally invasive access to tumor-derived biomarkers through the analysis of circulating tumor DNA, cell-free DNA, and extracellular vesicles such as exosomes. Unlik...

(This article belongs to the Special Issue Molecular Diagnostics and Cancer Research)
  • Article
  • Open Access
113 Citations
8,517 Views
13 Pages

Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial

  • François-Clément Bidard,
  • Nicolas Kiavue,
  • Marc Ychou,
  • Luc Cabel and ,
  • Marc-Henri Stern,
  • Jordan Madic,
  • Adrien Saliou,
  • Aurore Rampanou,
  • Charles Decraene and
  • Pascale Mariani
  • + 18 authors+ 13 authors

28 May 2019

The management of patients with colorectal cancer (CRC) and potentially resectable liver metastases (LM) requires quick assessment of mutational status and of response to pre-operative systemic therapy. In a prospective phase II trial (NCT01442935),...

(This article belongs to the Special Issue Circulating Tumor Cells: Finding Rare Events for A Huge Knowledge of Cancer Dissemination)
  • Article
  • Open Access
3 Citations
3,303 Views
15 Pages

The Prognostic Utility of KRAS Mutations in Tissue and Circulating Tumour DNA in Colorectal Cancer Patients

  • Joel Petit,
  • Georgia Carroll,
  • Jie Zhao,
  • Peter Pockney and
  • Rodney J. Scott

This study aims to investigate the long-term prognostic utility of circulating tumour DNA (ctDNA) KRAS mutations in colorectal cancer (CRC) patients and compare this with KRAS mutations in matched tissue samples. Tumour tissue (n = 107) and ctDNA (n...

(This article belongs to the Section Gastrointestinal Disease)
  • Article
  • Open Access
68 Views
13 Pages

Utilization of Circulating Tumor DNA Testing in Biliary Tract Cancers

  • Michael Sheu,
  • Nikolas Naleid,
  • Omkar Pawar,
  • Zhaohui Jin and
  • Amit Mahipal

5 November 2026

Background: Circulating tumor DNA is a promising biomarker for molecular residual disease and recurrence surveillance in biliary tract cancers. We evaluated the association between postoperative tumor-informed ctDNA and recurrence-free survival (RFS)...

(This article belongs to the Section Gastrointestinal Oncology)
  • Article
  • Open Access
13 Citations
3,934 Views
12 Pages

Cholangiocarcinoma is a malignant epithelial tumor arising from bile ducts that is frequently fatal. Diagnosis is difficult due to tumor location in the biliary tract. Earlier diagnosis requires less invasive methods of identifying effective biomarke...

(This article belongs to the Special Issue Recent Advances in Gastrointestinal Cancer)
  • Article
  • Open Access
13 Citations
2,780 Views
10 Pages

Predicting Response to Radical Chemoradiotherapy with Circulating HPV DNA (cHPV-DNA) in Locally Advanced Uterine Cervix Cancer

  • Susan Lalondrelle,
  • Jen Lee,
  • Rosalind J. Cutts,
  • Isaac Garcia Murillas and ,
  • Nik Matthews,
  • Nicholas Turner,
  • Kevin Harrington,
  • Katherine Vroobel,
  • Emily Moretti and
  • Shreerang A. Bhide
  • + 5 authors+ 0 author

22 February 2023

Background: The majority of locally advanced cervical cancers (LaCC) are causally related to HPV. We sought to investigate the utility of an ultra-sensitive HPV-DNA next generation sequencing (NGS) assay—panHPV-detect—in LaCC treated with...

(This article belongs to the Special Issue Gynaecological Cancer and Surgery: Current Practice, Novel Technologies and Future Developments)
  • Article
  • Open Access
53 Citations
4,554 Views
12 Pages

Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab

  • Angela Alama,
  • Simona Coco,
  • Carlo Genova,
  • Giovanni Rossi and ,
  • Vincenzo Fontana,
  • Marco Tagliamento,
  • Maria Giovanna Dal Bello,
  • Alessandra Rosa,
  • Simona Boccardo and
  • Francesco Grossi
  • + 10 authors+ 5 authors

10 July 2019

The treatment of advanced non-small cell lung cancer (NSCLC) has been revolutionized by immune checkpoint inhibitors (ICIs). The identification of prognostic and predictive factors in ICIs-treated patients is presently challenging. Circulating tumor...

(This article belongs to the Special Issue Liquid Biopsies in Lung Cancer)

of 46